期刊文献+

尾加压素Ⅱ、一氧化氮与慢性肺心病肺动脉高压的相关性研究 被引量:3

Correlation of urotensin Ⅱ and nitric oxide with pulmonary hypertension of chronic cardiopulmonary disease
下载PDF
导出
摘要 目的:研究血浆尾加压素Ⅱ(UⅡ)、一氧化氮(NO)水平与慢性肺心病患者肺动脉高压(PH)的相关性。方法:用超声心动图测量50例慢性肺心病患者的肺动脉收缩压(PASP),根据PASP大小分为对照组(〈30mmHg)、轻度PH组(30~49mmHg)、中度PH组(50~69mmHg)、重度PH组(≥70mmHg)。用放射免疫法测定血浆UⅡ水平,化学比色法测定血浆NO水平。结果:对照组、轻度PH组、申度PH组、重度PH组UⅡ水平分别为(1.82±0.83)pmol/L、(2.86士0.95)pmol/L、(3.38士1.04)pmol/L、(4.06±0.81)pmol/L。对照组与各PH组UⅡ水平有显著性差异(P〈0.05,P〈0.01),各PH组问也有差异性(P〈0.05)。血浆UⅡ水平与肺动脉压力呈正相关(r=0.648,P〈0.05)。对照组、轻度PH组、中度PH组、重度PH组NO水平分别为(50.01±9.79)umol/L、(74.92±49.83)umol/L、(75.00±26.29)umol/L、(72.32±26.74)umol/L。对照组与各PH组NO水平有显著性差异(P〈0.01),各PH组同无差异。血浆NO水平与肺动脉压力无相关性。结论:UI在PH形成和血管重建中起重要作用.NO增高在PH形成中起保护作用,血浆UⅡ水平可作为判断PH严重程度的指标之一。 Objective:To investigate the correlation of plasma urotensin Ⅱ and nitric oxide level with pulmonary hypertension(PH) in patients with chronic cardiopulmonary disease. Methods:The pulmonary artery systolic pressure (PASP) in 50 patients with chronic cardiopulmonary disease was measured by echocardiography. The patients were divided into four groups according to PASP: control group (〈30mmHg), mild PH group (30-49mmHg),moderate PH group (50-69mmHg) and severe PH group (≥70mmHg). Plasma urotensin I was measured by radioimmunoassay, and plasma nitric oxide was measured by colorimetric assay. Results:The plasma urotensin Ⅱ levels in control group,mild PH group, moderate PH group and severe PH group were (l. 82±0. 83)pmol/L, (2. 86±0.95)pmol/L, (3.38±1.04) pmol/L and (4. 06± 0. 81)pmol/L,respectively. There was marked difference between the normal group and every PH group (P 〈 0.05 ,P 〈 0. 0l) ,and difference in various PH groups (P 〈 0. 05). The plasma urotensin Ⅱ level was positively correlated with the pulmonary arterial pressure (r = 0. 648,P 〈 0.05). The nitric oxide level in control group, mild PH group,moderate PH group and severe PH group was (50. 01±9. 79)umol/L, (74. 92±49. 83)umol/L, (75.00±26. 29)umol/L and (72. 32±26. 74)umol/L, respectively. There was marked difference between the normal group and every PH group (P 〈 0. 01) and no difference in different PH groups. The plasma nitric oxide level was not correlated with the pulmonary arterial pressure. Conclusion:With the increase in PH severity,the plasma urotensin Ⅱ level increases. The plasma urotensin Ⅱ plays an important role in the formation of PH and restructure. And the plasma nitric oxide level may play a protective role in the pathogenesis of PH. The plasma urotensin Ⅱ level may be a reliable index to show the change of pulmonary pressure and PH severity.
出处 《黑龙江医药科学》 2008年第1期10-11,共2页 Heilongjiang Medicine and Pharmacy
基金 黑龙江省教育厅研究生创新科研项目(编号:YJSCX2007-0090HLJ)
关键词 尾加压素Ⅱ 一氧化氮 肺动脉高压 urotensin Ⅱ nitric oxide pulmonary hypertension
  • 相关文献

参考文献1

二级参考文献11

  • 1[1]Pearson D, Shively JE, Clark BR, et al. Urotensin-II: a somatostatin-like peptide in the caudal neurosecretory system of fishes[J]. Proc Natl Acad Sci USA, 1980,77(8):5021-5024.
  • 2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of the cDNA encoding the urotensin-II precursor in frog and human reveals intense expression of the urotensin-II gene in motoneurons of the spinal cord[J]. Proc Natl Acad Sci USA ,1998,95(26):15803-15808.
  • 3[3]Liu Q, Pong SS, Zeng Z, et al. Identification of urotensin-II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14[J]. Biochem Biophys Res Commol/Lun,1999, 266(1):174-178.
  • 4[4]JD, Liu WS, Glover GI, Wilson S, et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J]. Nature,1999,401(6750):282-286.
  • 5[5]Rossowski WJ, Cheng BL, Taylor JE, et al. Human urotensin-II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists[J]. Eur J Pharmacol,2002,438(3):159-170.
  • 6[6]Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin-II with serotonin on vascular smooth muscle cell proliferation[J]. J Hypertens,2001,19(12):2191-2196.
  • 7[7]Ishihata A, Tasaki K, Katano Y, et al. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta[J]. Eur J Pharmacol,2002,445(3):247-256.
  • 8[8]Maguire JJ, Kuc RE, Davenport AP, et al. Orphan-receptor ligand human urotensin-II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1[J]. Br J Pharmacol,2000,131(3):441-446.
  • 9[9]Elshourbagy NA, Douglas SA, Shabon U, et al. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey[J]. Br J Pharmacol,2002,136(1):9-22.
  • 10[10]Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey[J]. Br J Pharmacol,2000,131(7):1262-1274.

共引文献7

同被引文献30

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部